Abstract:Tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 (TNFAIP8L2; also termed TIPE2) has been shown to be involved in both the immune-negative modulation and cancer. We previously found that TIPE2 is lost in human gastric cancer, and TIPE2 restoration suppresses gastric cancer growth by induction of apoptosis and impairment of protein kinase B (PKB/AKT) and extracellular signal-regulated kinase-1/2 (ERK1/2) signaling. However, its correlation with epithelial–mesenchymal transition (EMT) in gastric cancer is largely elusive. In the present report, we carried out a gain-of-function study in AGS and HGC-27 human gastric cancer cells by adenovirus-mediated human TIPE2 gene transfer (AdVTIPE2). We then examined the effects of AdVTIPE2 on in vitro migration and invasion of AGS and HGC-27 tumor cells by wound-healing assay and Transwell invasion assay, respectively. We also investigated the effects of AdVTIPE2 on in vivo lung metastasis of AGS and HGC-27 tumor cells by intravenous (i.v.) injection in athymic BALB/c nude mice. We demonstrated that AdVTIPE2 remarkably suppressed the migratory, invasive and metastatic potential of AGS and HGC-27 tumor cells in vitro and in vivo in BALB/c nude mouse model. Mechanistically, AdVTIPE2 obviously upregulated E-cadherin epithelial marker in AGS and HGC-27 tumor cells, whereas it downregulated N-cadherin and Vimentin mesenchymal markers, Snail1, Snail2/Slug and Zeb1 EMT-inducing transcription factors (EMT-TFs), and tripartite motif-containing 29 (TRIM29) and phosphatase regenerating liver 3 (PRL-3) gastric cancer-specific metastasis markers. Importantly, glycogen synthase kinase-3β (GSK-3β) inhibitor VIII and 26S proteasome inhibitor MG132 assays revealed that TIPE2 downregulated Snail1 and Snail2/Slug in a GSK-3β- and proteasome-dependent manner possibly by impairing AKT signaling. Our data provided the first evidence that TIPE2 inhibits gastric cancer cell migration, invasion and metastasis very probably via reversal of EMT, revealing that TIPE2 may be a novel therapeutic target for human gastric cancer EMT and metastasis.

Tumor Necrosis Factor (Tnf)-Α-induced Protein 8-Like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.

Tipe2 Suppresses the Tumorigenesis, Growth and Metastasis of Breast Cancer Via Inhibition of the Akt and P38 Signaling Pathways

Gene Delivery of TIPE2 Inhibits Breast Cancer Development and Metastasis Via CD8+ T and NK Cell-Mediated Antitumor Responses.

TIPE3 Protein Promotes Breast Cancer Metastasis Through Activating AKT and NF-κB Signaling Pathways

TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway

TIPE2 Inhibits GC Via Regulation of Cell Proliferation, Apoptosis and Inflammation

TIPE2 inhibits melanoma progression through MEK/ERK signaling

Regulatory Roles of Tumor Necrosis Factor-α-Induced Protein 8 Like-Protein 2 in Inflammation, Immunity and Cancers: A Review

TIPE1 function as a prognosis predictor and negative regulator of lung cancer

The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras.

A Novel Prognostic Factor TIPE2 Inhibits Cell Proliferation and Promotes Apoptosis in Pancreatic Ductal Adenocarcinoma (PDAC)

TIPE2: A Candidate for Targeting Antitumor Immunotherapy.

Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression

Tipe2 Functions As A Metastasis Suppressor Via Negatively Regulating Beta-Catenin Through Activating Gsk3 Beta In Gastric Cancer

Adenovirus-mediated TIPE2 Overexpression Inhibits Gastric Cancer Metastasis Via Reversal of Epithelial–mesenchymal Transition

Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) upregulates p27 to decrease gastic cancer cell proliferation.

Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint

TIPE2 inhibits the migration and invasion of epithelial ovarian cancer cells by targeting Smad2 to reverse TGF-β1-induced EMT

Clinical Significance of TIPE Expression in Gastric Carcinoma.

Expression of TIPE family members in human colorectal cancer

TIPE2 Suppresses Progression and Tumorigenesis of Esophageal Carcinoma Via Inhibition of the Wnt/β-catenin Pathway